AI heart scanner put to the test on 200,000 patients

NCT ID NCT07333547

Recruiting now Knowledge-focused Sponsor: Idoven 1903 S.L. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This registry study will enroll 200,000 high-risk cardiac patients to see how well an AI platform called Willem can detect heart problems from standard ECGs. The AI's readings will be compared to expert cardiologist diagnoses, but the AI results won't be shared with doctors, so patient care stays the same. The goal is to gather evidence on whether AI can reliably interpret ECGs in real-world hospital settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show that AI can reliably read ECGs, potentially helping doctors spot heart issues faster and more accurately in the future.
What could go wrong: This is an observational study, not a treatment trial. The AI results are not used in patient care, so any benefit is still theoretical. The large size may reveal limitations in real-world accuracy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIGH-RISK CARDIAC PATIENTS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

CardioHeredia
RECRUITING

Guayaquil, Guayas, 090101 - 090158, Ecuador
La Paz University Hospital
NOT_YET_RECRUITING

Madrid, 28046, Spain
Murcia University
NOT_YET_RECRUITING

Murcia, 30100, Spain
Puerta de Hierro University Hospital
RECRUITING

Madrid, 28222, Spain
Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.